Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Brivaracetam: a Prospective and Multicentre Post-marketing Observational Study

NCT03517423 is registered in ClinicalTrials.gov with Centre hospitalier de l'Université de Montréal (CHUM) as lead sponsor.

NCT NCT03517423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03517423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Brivaracetam: a Prospective and Multicentre Post-marketing Observational Study
Lead sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Phase
Observational
Overall status
Completed
Start date
October 4, 2018
Completion date
August 29, 2023
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy